KDR and colonic neoplasm: By targeting VEGFR-2, these newlysynthesized benzimidazole derivativeshold promise as potential antiangiogenic agents for colon cancer treatment.The findings from this study contribute to the ongoing search forselective and potent VEGFR-2 inhibitors with improved efficacy andtherapeutic potential.